APA (7th ed.) Citation

AL, O., ML, M., ATP, C., CL, C., FZ, M., & E, A. (2025). The RAGE Inhibitor TTP488 (Azeliragon) Improves Diabetic Bladder Dysfunction in Leptin-Deficient Obese Mice. Antioxidants (Basel, Switzerland), 14(7), . https://doi.org/10.3390/antiox14070793

Chicago Style (17th ed.) Citation

AL, Oliveira, Medeiros ML, Campos ATP, Cesar CL, Mónica FZ, and Antunes E. "The RAGE Inhibitor TTP488 (Azeliragon) Improves Diabetic Bladder Dysfunction in Leptin-Deficient Obese Mice." Antioxidants (Basel, Switzerland) 14, no. 7 (2025). https://doi.org/10.3390/antiox14070793.

MLA (9th ed.) Citation

AL, Oliveira, et al. "The RAGE Inhibitor TTP488 (Azeliragon) Improves Diabetic Bladder Dysfunction in Leptin-Deficient Obese Mice." Antioxidants (Basel, Switzerland), vol. 14, no. 7, 2025, https://doi.org/10.3390/antiox14070793.